[Outcome of treating initial tuberculosis in the area south of Seville in a 5-year period (1994-1998]

Arch Bronconeumol. 2001 Apr;37(4):177-83. doi: 10.1016/s0300-2896(01)75047-8.
[Article in Spanish]

Abstract

Objective: To analyze the outcome of treating initial tuberculosis (ITB) in the hospital district south of Seville (Spain).

Material and method: A descriptive study of treatment outcome in cases of ITB in our district between 1 January 1994 and 31 December 1998. Outcome was classified according to World Health Organization guidelines:successful (S) potentially unsuccessful (PU), exitus (EX) and transferred out (T).Four hundred fifty-four patients (mean age 35 years) were enrolled; 22% were HIV+ and 21% were intravenous drug users (IVDU). Treatment was self-administered in all cases, with 98% being given the standard prescription of 6 or 9 drugs. No subsequent case history was found for 15 cases, such that outcome could not be assessed.

Results: Of the 439 evaluable cases, outcome was S for 74% (326/439), PU for 16% (70/439), EX for 8% (36/439) and T for 6. Outcome for HIV + patients was poorer than for HIV- patients (S: 35/98 versus 291/341, p < 0.00005;PU: 40/98 versus 30/341, p < 0.00005), and the mortality rate of HIV+ patients was higher than that of HIV- patients (EX:18/98 versus 18/341, p < 0.0008). Among those classified PU,no cases of treatment failure were recorded and up to 78% (31/40)were cases of loss of follow-up or abandonment. The variable most closely related to PU was IVDU status (OR = 10.5, p < 0.00005).

Conclusion: a) Outcomes for the general population are acceptable. b)A marginal group has been identified as characterized by two variables, HIV+ and IVDU, which are the factors associated with poorer outcome of self-administered treatment, indicating that supervised treatment is advisable in cases where those factors are present.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antitubercular Agents / therapeutic use*
  • Drug Therapy, Combination
  • HIV Infections / complications
  • Humans
  • Middle Aged
  • Regression Analysis
  • Risk Factors
  • Spain / epidemiology
  • Treatment Outcome
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / mortality

Substances

  • Antitubercular Agents